Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company provides its products to ophthalmology, antipyretic and analgesic, antibacterial anti-inflammatory, endocrine, auxiliary, cardiovascular, detoxification, diuretic row stone, gynecology, and infusion categories. It offers its products in injections, oral solutions, eye drops, tablets, capsules, and other dosage forms. Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. was founded in 1978 and is based in Pinghu, China.

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.

浙江莎普爱思药业股份有限公司 is involved in the development and production of pharmaceutical products, specifically focusing on eye care medications, including treatments for cataracts and other eye conditions.

Metric
Company Name	Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.
Symbol	603.17K
MSH ID	COM:ZJSPAS
Market	STOCKS
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
Country	CN
Stage
Employee Count	1.39K
Website	zjspas.com
LinkedIn
Founders

Metric
Market Cap	359.42M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	89.15M
Revenue (LTM)
Revenue (NTM)
Gross Profit	49.90M
EBITDA	16.28M
Operating Income	3.05M
Net Income	3.51M
EPS	0.01
Diluted EPS	0.01
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.57
Operating Profit Margin	0.11
EBITDA Margin	0.18
Net Profit Margin	0.13
Return on Equity	0.05
Return on Assets	0.04
Return on Capital Employed	0.04

6031

COM:ZJSPAS

浙江莎普爱思药业股份有限公司

Last Close

8.78

22/11 07:00

Market Cap

2.57B

Beta: -

Volume Today

22.75M

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	39.43
P/B Ratio	1.78
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	6.19
EV Multiple	187.19

Metric
Days Sales Outstanding	67.16
Days Payables Outstanding	48.28
Days Inventory Outstanding	122.87
Operating Cycle	190.03
Cash Conversion Cycle	141.75
Asset Turnover	0.30

Metric
Operating Cash Flow	5.74M
Free Cash Flow	-24.64M
Cash Flow to Debt	0.40
Operating Cash Flow/Sales	0.11
Free Cash Flow Yield	-0.06

Metric
Cash & Equivalents	49.16M
Accounts Receivable	-1.66M
Inventory	11.65M
Goodwill	50.51M
Debt to Capitalization	0.11
Debt to Assets	0.08
Current Ratio	2.71
Quick Ratio	2.30

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue	0.11
SG&A to Revenue	0.15